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Abstract
Background: Lower limb amputation is correlated with considerable impairments in health-related quality of
life (HRQOL) in veterans. The aim of this study is to determine the prevalence of metabolic syndrome (MetS)
in veterans with bilateral lower limb amputation and to identify its association with HRQOL.
Methods: This cross-sectional study was conducted on 235 Iranian male veterans with bilateral lower limb
amputation. Demographics, anthropometrics, and biochemical measurements were assessed and MetS was
defined by National Cholesterol Education Program Adult Treatment Panel III definition. HRQOL was assessed
using the 36-item Short Form Health Survey (SF-36) questionnaire which measures eight health-related domains.
The scores were compared between two groups of bilateral lower limb Amputees who have diagnosed with and
without MetS.
Results: The response rate was 40.7% and the mean age of the amputees was 52.05 years. 62.1% of participants
were suffering from MetS (95% CI: 55.9%–68.4%). Patients with MetS were observed to have higher weight, waist
and hip circumferences, FBS, TG, LDL and liver enzymes concentrations (P < 0.05). Although scores on all 8 subscales of
SF-36 were low, no significant difference was observed in HRQOL scores between amputees with and without MetS.
Moreover, the risk of MetS was not significantly different across subjects in the highest compared to the lowest quartile
category of HRQOL scores.
Conclusions: Prevalence of MetS in veterans with bilateral lower limb amputation was higher and their HRQOL was
lower compared to general population. Some strategies are needed to reduce the risk of cardiovascular diseases among
this susceptible population.
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Background
War has a far-reaching impact on the health and well-
being of the soldiers, war veterans, victims and even on
the population as a whole [1]. Imposed Iran–Iraq war was
one of the longest military conflicts in the 20th century.
The health-related effects of war on soldiers and veterans
including amputation have been widely studied [2–5]. The
most common cause of amputation in Iranian veterans in
Iran–Iraq war is land mine accovunting for 89.7% of injur-
ies, and lower limb amputation is the most common type
of amputation [6] which is associated with considerable
morbidity, mortality, and disability [7].
Since lower limb amputees have major progressive
disabilities in their daily activities and social performance
[8], it may affect the individual’ weight and subsequently
leads to metabolic syndrome and cardiovascular diseases
[9, 10]. Metabolic syndrome is defined as a pattern of
metabolic disturbances including central obesity, insulin
resistance and hyperglycemia, dyslipidemia, and hyper-
tension. The third report of the National Cholesterol
Education Program Adult Treatment Panel III (ATP III)
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recognized the metabolic syndrome as a secondary tar-
get of risk-reduction therapy [11]. On the other hand,
the negative effect of MetS on Health-Related Quality
of life (HRQOL) have been reffered to in some studies
[12, 13]. However, the quality of life status in veterans
with or without metabolic syndrome has not been ex-
plored completely among the so called population. Thus,
we decided to identify the prevalence of metabolic syn-
drome in veterans and to explore the relationship between
the quality of life and factors associated with metabolic
syndrome in veterans with bilateral lower amputation.
Methods
The ethics committee of Janbazan Medical and Engineering
Research Center (JMERC) approved the study (No.
85-E-P-102, date of approval: November 29, 2006)
and written informed consents were obtained from all
veterans.
This was a cross-sectional study which was con-
ducted on 235 male veterans with bilateral lower limb
amputation who were supported by the Veterans and
Martyrs Affairs Foundation (VMAF). This foundation
holds comprehensive data of all civilians and veterans
of the Iran-Iraq War, who are suffering from clinical
health problems and disabilities [14]. Out of 578 vet-
erans with bilateral lower limb amputation supported
by the VMAF, 235 veterans participated in this study
(response rate was 40.7%). Demographic data including
age, level of education, employment status, marital
status, and clinical data including level of amputation,
sport activity, cause and time of amputation were col-
lected using a questionnaire. Anthropometric measure-
ments including weight, waist and hip circumferences
and blood pressure were measured by trained physi-
cians. Weight was measured to the nearest 100 g using
special digital scales for amputees, in sitting position
while the participants were minimally clothed, without
prosthesis. Waist circumference (WC) was measured at
the point of noticeable waist narrowing, hip circumfer-
ence (HC), measured at the widest girth of the hip and
waist-to-hip ratio (WHR) more than 0.9 was considered
as abdominal obesity [15]. Blood pressure was mea-
sured two times after 15 min resting in the seated pos-
ition by a standard mercury sphygmomanometer of the
right arm of the subjects. The mean of 2 measurements
was considered as the participant’s blood pressure. For
biochemical measurements, blood samples were taken
from the participants after 12–14 h fasting. Enzymatic
colorimetric tests were used for measuring fasting blood
glucose (FBG), total cholesterol (TC) and triglyceride (TG)
levels. High-density lipoprotein cholesterol (HDL-C) was
measured after the precipitation of the apolipoprotein B-
containing lipoproteins with phosphotungstic acid. Low-
density lipoprotein cholesterol (LDL-C) was calculated
from serum TC, TG, and HDL-C using the Friedwald for-
mula [16]. Serum glutamate oxaloacetate transaminase
(SGOT) and serum glutamate pyruvate transaminase
(SGPT) were analyzed by enzymatic calorimetric methods.
Creatinine (Cr) and blood urea nitrogen (BUN) levels were
also measured by automated biochemistry machine aac-
cording to the standard procedure of Pars azmoon kits.
Metabolic syndrome
The presence of MetS was determined in participants in
accordance with the definition provided by the National
Cholesterol Education Program-Adult Treatment Panel
III (ATP III). According to the ATP III definition, MetS
was defined as having 3 or more of the following
metabolic abnormalities: (1) high FBG ≥100 mg/dl or
use of medication, (2) high TG ≥150 mg/dl or use of
medication, (3) low HDL-C <40 mg/dl, (4) elevated
blood pressure ≥130/85 mmHg or use of medication and
(5) High WC ≥95 cm [17, 18].
Health related quality of Life
Health related quality of life (HRQOL) was assessed
using the 36-item generic questionnaire (SF-36) which is
used for the general population or for different patient
groups. The questionnaire contains 36 items for evaluat-
ing 8 health-related domains, including physical function
(PF), physical role (PR), general health (GH), bodily pain
(BP), vitality (VI), social functioning (SF), emotional role
(RE), and mental health (MH) and also two summary
scales, Physical Component Summary (PCS) and Mental
Component Summary (MCS). The scores were trans-
formed to a range of 0 (worst HRQOL) to 100 (best
HRQOL). The eight scales are hypothesized to form two
distinct clusters)physical and mental health(. The scales
including Physical Functioning, Role Physical, and Bodily
Pain were founded to be most highly correlated with the
physical component and contributed most to the scoring
of the Physical Component Summary (PCS) measure. As
well, Mental Health, Role Emotional, and Social Func-
tioning scales were mostly correlated with the mental
component and contributed most to the scoring of the
Mental Component Summary (MCS). These findings
demonstrated that those scales putting more emphasis
on the physical component are most responsive to treat-
ments that change physical morbidity. In contrast, those
scales focusing on the mental component responded the
most to therapies that targeted mental health [19, 20].
The psychometric properties of the Iranian version of
the SF-36 examined in a previous study indicated that the
internal consistency (to test reliability) for all eight SF-36
scales met the minimum reliability standard, the Cronba-
ch's α coefficients ranging from 0.77 to 0.90 with the ex-
ception of the vitality scale (alpha = 0.65). The known
groups comparison showed that in all scales the SF-36
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discriminated between men and women, and old and
young respondents as anticipated (all P values less than
0.05). Convergent validity (to test scaling assumptions)
using each item correlation with its hypothesized scale
showed satisfactory results (all correlation above 0.40
ranging from 0.58 to 0.95). Factor analysis identified two
principal components that jointly accounted for 65.9% of
the variance [20].
Statistical analysis
All statistical analyses were conducted using SPSS (Version
16.0; SPSS Inc, Chicago, IL). P values < 0.05 was considered
significant. Continuous variables are reported as the mean
± standard deviation and categorical variables as percent-
ages. Participant demographic characteristics, anthropo-
metric and biochemical measurements were compared
between two groups of bilateral lower limb amputees with
and without MetS using the Independent Samples T-Test
or Mann–Whitney U test or the Chi-square test. The
HRQOL scores were compared between two groups of
bilateral lower limb amputees with and without MetS using
the Independent Samples T-Test or Mann–Whitney U test.
The HRQOL scores were categorized by using quartile
cutoffs. Incident odds ratio (OR) with 95% confidence
intervals (CI) were obtained using multivariable logistic
regression. Logistic regression was used to assess the
relationship of HRQOL scores and risk of MetS. In multi-
variable models, we adjusted for age, weight without
prosthesis, physical activity, smoking status and additional
war-related injuries.
Results
The mean age of the amputees was 52 ± 6.05 years and the
mean age at the time of amputations was about 31.5 years.
In 97.4% of subjects bullet was the cause of amputations
and 62.6% of amputees had other injuries including upper
extremity, visceral, face and head injuries. The majority of
the participants (97.9%) were married. 62.1% of amputees
were suffering from MetS (95% CI: 55.9%–68.4%). Demo-
graphic characteristics of amputees classified as having
MetS or not are summarized in Table 1. No significant dif-
ference was observed in demographic variables, between
subjects with and without MetS except for age and dur-
ation of right and left legs amputations. The participants
with MetS were older (mean age: 52.7 ± 5.5 vs. 51.0 ±
6.6 years; P < 0.05) with longer duration of right and left
legs amputations (32.1 ± 3.4 vs. 30.8 ± 4.1; P < 0.01 and
32.1 ± 3.4 vs. 30.6 ± 4.4; P < 0.005, respectively). As illus-
trated in Table 2, the mean weight, waist and hip circum-
ferences, systolic and diastolic blood pressure, triglyceride,
HDL and LDL cholesterol and liver enzymes concentra-
tions (SGOT and SGPT) were significantly higher in the
amputees with MetS compared to subjects without MetS
(P < 0.05). HRQOL scores were compared in two groups of
amputees are presented in Table 3. We observed no signifi-
cant difference in 8 health-related domains and also two
summary scales of HRQOL between subjects with and
those without MetS. OR and 95% CI of MetS in each quar-
tile category of HRQOL scores are shown in Table 4. The
risk of MetS was not significantly different across subjects
in the highest compared to the lowest quartile category
of HRQOL scores even after adjustment for age, weight
without prosthesis, physical activity, smoking status
and additional war-related injuries.
Discussion
In this study we evaluated the prevalence of MetS, as an
important public health problem, among Iranian male
veterans with bilateral lower amputation and compared
the health related quality of life in them according to
having MetS or not.
Our cross-sectional findings showed a higher preva-
lence of MetS in veterans with bilateral lower amputa-
tions in comparison with general populations. In our
study, the prevalence of MetS among amputees was
62.1% (95% CI: 55.9%–68.4%) while, according to the
definition of US National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP ATP III), 23.7%
of the world wide general populations [21] and about
27% of Iranian populations [22] suffer from MetS. Pa-
tients with lower limb amputations appear to be two
times more in risk of developing of metabolic disorders
including obesity, hypertension, hyperlipidemia, and
hyperinsulinemia [23, 24]. Moreover, high prevalence of
metabolic syndrome among patients with lower limb
Table 1 Demographic characteristics in bilateral lower limb






(n = 89) (n = 146)
Age (years) 51.0 ± 6.6 52.7 ± 5.5 0.048
Duration of right leg
amputation (years)
30.8 ± 4.1 32.1 ± 3.4 0.006
Duration of left leg
amputation (years)
30.6 ± 4.4 32.1 ± 3.4 0.004
Educational status 0.586
<12 years (%) 41.6 45.2
≥12 years (%) 58.4 54.8
Married (%) 97.8 97.9 0.627
Having sport activity (%) 57.1 48.9 0.234
Smokers (%) 34.8 27.8 0.256
Cause of amputation 0.412




Data represented as mean ± SD or frequency (%)
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problems is reported. In studies conducted on patients
with critical lower limb ischemia (CLI) and peripheral
arterial disease (PAD), the prevalence of MetS was
reported 52% and 63%, respectively [25, 26]. Peles et al.
compared the insulin resistance between lower limb am-
putees and healthy controls with similar age, body mass
index, blood pressure and plasma lipid levels. Amputees
were found to have significantly higher fasting plasma
insulin levels and insulin response to oral glucose with
similar plasma glucose levels [27]. Modan et al. also
showed increased levels of insulin in amputees compared
to healthy controls after adjustment for age, smoking,
physical activity, body mass index, mean arterial blood
pressure and cholesterol [28]. Rose et al. in a study
showed that veterans with bilateral above-knee amputa-
tions had significantly higher blood pressure, mean body
fat content, weight and insulin levels compared to age
matched unilateral below-elbow amputees [9]. These re-
sults confirm our findings indicating that high prevalence
of MetS in amputees. There are so many factors that in-
crease the risk of MetS in the general population, such as
genetic factors, sedentary lifestyle, unhealthy diets with
high levels of fat and sugar, which lead to the forma-
tion of advanced glycation end products and unbal-
anced gut microbiota composition [29–32].
Furthermore, amputees with physical disabilities and
inactive lifestyles are at higher risk of obesity and re-
lated metabolic disorders. However, the present study
has not evaluated the dietary intake of participants
which is an effective factor in MetS.
Logestic regression findings in this study showed no
significant association between HRQOL scores and
MetS in amputees even after adjustment for age, weight
Table 3 Comparison of the HRQOL scores in bilateral lower






(n = 89) (n = 146)
Physical
Functioninga
53.4 ± 24.4 54.9 ± 24.5 0.667
General Healtha 55.3 ± 27.1 56.3 ± 26.8 0.784
Vitalitya 65.3 ± 25.0 64.4 ± 21.5 0.777
Mental Healtha 63.5 ± 27.0 65.4 ± 24.1 0.585
Role-Physicalb 36.4 (36.4–75.0) 36.4 (36.4–75.0) 0.664
Bodily Painb 42.6 (22.0–61.0) 42.6 (32.0–66.0) 0.371
Social Functioningb 75.0 (56.0–100.0) 64.2 (50.0–87.5) 0.549
Role-Emotionalb 43.7 (43.7–100.0) 43.7 (43.7–100.0) 0.564
Physical Component
Scalea
46.5 ± 24.5 47.8 ± 22.1 0.681
Mental Component
Scalea
60.7 ± 27.8 59.7 ± 25.0 0.777
Data represented as mean ± SDa or median (Quartiles 25–75)b
Table 4 Odds ratio and 95% confidence interval for MetS across
quartile categories of the HRQOL scores
Quartiles of HRQOL scores Model 1 Model 2
OR 95% CI OR 95% CI
Physical component scale
Q1(reference)
Q2 0.90 0.43–1. 91 1.25 0.53–2.98
Q3 0.92 0.43–1.95 1.34 0.56–3.20
Q4 1.08 0.51–2.27 1.25 0.52–2.98
Mental component scale
Q1(reference)
Q2 1.12 0.54–2.32 1.31 0.55–3.13
Q3 1.79 0.84–3.82 1.22 0.52–2.85
Q4 1.43 0.68–2.99 0.85 0.35–2.01
Model 1: Unadjusted logistic regression model
Model 2: Logistic regression model with adjustment for age, weight without
prosthesis, physical activity, smoking status and additional war-related injuries
Table 2 Comparison of the anthropometric and biochemical
measurements in bilateral lower limb amputees according to






(n = 89) (n = 146)
Weight without
prosthesis (kg)a
67.6 ± 13.1 76.4 ± 13.0 <0.001
Waist circumference
(cm)a
95.3 ± 10.7 107.1 ± 11.3 <0.001
Hip circumference
(cm)a
98.8 ± 10.9 108.7 ± 11.6 <0.001
Waist to hip ratio (cm)a 0.97 ± 0.1 0.99 ± 0.1 0.037
Systolic blood pressure
(mmHg)a
120.4 ± 15.2 132.9 ± 22.4 <0.001
Diastolic blood
pressure (mmHg)a
77.3 ± 11.3 91.5 ± 61.3 0.032
Fasting blood sugar
(mg/dl)a
88.2 ± 16.6 112.4 ± 47.6 <0.001
Creatinine (mg/dl)a 0.9 ± 0.7 0.8 ± 0.2 0.422
Blood urea nitrogen
(mg/dl)b
18.0 (11.0–27.0) 17.0 (12.0–27.0) 0.836
Triglyceride (mg/dl)b 132.0 (95.5–208.0) 214.0 (153.5–275.5) <0.001
Total cholesterol
(mg/dl)a
191.8 ± 40.5 202.1 ± 50.8 0.109
LDL- cholesterol
(mg/dl)a
115.8 ± 36.1 128.1 ± 46.8 0.042
HDL- cholesterol
(mg/dl)a




24.0 (17.0–28.0) 26.0 (19.0–33.0) 0.028
Serum glutamic-pyruvic
transaminase (mg/dl)b
24.0 (15.0–37.5) 31.0 (21.0–43.0) 0.003
Data represented as mean ± SDa or median (Quartiles 25–75)b
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without prosthesis, physical activity, smoking status
and additional war-related injuries. It seems that other
factors such as sedentary life style are more effective in
weight and related metabolic abnormalities than the
quality of life in this group of individuals [9, 10]. In pre-
vious studies poorer HRQOL in lower limb amputees
have been revealed in comparison with general popula-
tion [3, 33–35]. Indeed, physical inactivity caused by
amputation could affect the quality of life in amputees.
However, there are limited studies concerning the
evaluation of HRQOL in amputees according to their
metabolic disorders. Different factors including pain,
depression, social supports, prosthesis problems and
social activity participation may have effect on HRQOL
in amputees [3, 36]. The relatively no association
between Mets and HRQOL is found in veterans with
bilateral lower limb amputations. Therefore, we con-
clude that although having the major disabily could be
strong enough to cause poor quality of life [3], poor
quality of life alone could not be associated with health
burden in this population. The association of metabolic
abnormalities with HRQOL has been assessed in
previous studies. Jahangiri et al. demonstrated negative
relationship between HRQOL and MetS. They declared
that abdominal obesity and high blood pressure are
associated with lower HRQOL in the participants with
MetS [12]. Tsai et al. revealed that participants with
MetS had lower scores on physical function and general
health [37]. Porter et al. showed that obesity, diabetes,
vascular disease, and heart diseases were significantly
related with low HRQOL [38]. However, some studies
reported no significant changes in HRQOL in individ-
uals with metabolic abnormalities. Lopez-Garcia et al.
in a study evaluated the HRQOL in normal-weight and
obese individuals with or without metabolic abnormal-
ities and revealed that compared to healthy normal-
weight subjects, the metabolically unhealthy normal-
weight and the healthy obese individuals had a similar
HRQOL [39]. The other study in Iran that used the
different questionnaire for evaluating quality of life
reported no association between quality of life factors
and MetS in men [40]. Therefore the association be-
tween MetS and HRQOL is still under investigation
and more detailed studies are recommended especially
in veterans with bilateral lower amputation as a group
with high prevalence of MetS in order to decide
compensation policies. There are some limitations in
this study. It was conducted on a part of veterans with
bilateral lower amputation and the results are not
representative of the population as a whole and cannot
be generalized. Moreover, due to the cross-sectional na-
ture of this study, no causality could be found between
bilateral lower limb amputation and MetS. Besides, no
comparison with non-veterans amputees or healthy
population as control groups, was conducted. So,
further long-term studies with the aim of assessing the
effect of HRQOL on MetS in this group of veterans are
suggested.
Conclusion
In conclusion, our findings reveal a high prevalence of
MetS and low HRQOL in veterans with bilateral lower
amputation. Although there was no significant difference
in HRQOL between subjects with Mets and those
without MetS, close monitoring of these patients for
concomitant diseases such as diabetes mellitus and heart
diseases and improving their HRQOL by using effective
method is necessary.
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